Trials / Completed
CompletedNCT00179348
Yoga-Based Rehabilitation Program in Reducing Physical and Emotional Side Effects in Patients With Cancer
Evaluation of a Yoga-Based Cancer Rehabilitation Program
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 399 (actual)
- Sponsor
- Albert Einstein College of Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This clinical trial studies yoga-based rehabilitation in reducing physical and emotional side effects of living with cancer or its treatment. Yoga-based rehabilitation may reduce side effects and improve the quality of life of patients with breast, lung, or colorectal cancer.
Detailed description
PRIMARY OBJECTIVES: I. To evaluate the effects of yoga on quality of life (QOL) of breast cancer patients on different treatment regimens. II. To pilot the effects of a yoga-based rehabilitation program versus standard care on QOL impairment reported by newly diagnosed (a) lung and (b) colorectal patients. III. To evaluate program compliance and satisfaction among breast, lung and colorectal cancer patients as well as among the various sociocultural subgroups (e.g., ethnicity, language). OUTLINE: Participants are randomized to 1 of 2 arms. GROUP I (YOGA-BASED REHABILITATION PROGRAM): Participants undergo a yoga-based rehabilitation program up to 5 days a week for 1.5 hours and practice at home at least once daily for 12 weeks. GROUP II (STANDARD CARE/CONTROL): After a 3 month wait period, participants undergo yoga-based rehabilitation program as in Group I.
Conditions
- Alopecia
- Anxiety
- Breast Carcinoma
- Cognitive Side Effects of Cancer Therapy
- Colorectal Carcinoma
- Depression
- Fatigue
- Lung Carcinoma
- Nausea and Vomiting
- Pain
- Psychological Impact of Cancer
- Sleep Disorder
- Weight Change
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Quality-of-Life Assessment | Ancillary studies |
| PROCEDURE | Yoga | Undergo a yoga-based rehabilitation program |
Timeline
- Start date
- 2001-02-08
- Primary completion
- 2016-07-20
- Completion
- 2016-07-20
- First posted
- 2005-09-16
- Last updated
- 2023-05-31
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00179348. Inclusion in this directory is not an endorsement.